These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2737955)

  • 21. Studies on a novel antitumor antibiotic, phenazinomycin: taxonomy, fermentation, isolation, and physicochemical and biological characteristics.
    Omura S; Eda S; Funayama S; Komiyama K; Takahashi Y; Woodruff HB
    J Antibiot (Tokyo); 1989 Jul; 42(7):1037-42. PubMed ID: 2753810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycophenolic acid: antiviral and antitumor properties.
    Williams RH; Lively DH; DeLong DC; Cline JC; Sweeny MJ
    J Antibiot (Tokyo); 1968 Jul; 21(7):463-4. PubMed ID: 4303502
    [No Abstract]   [Full Text] [Related]  

  • 23. Powerful new inhibitor of murine leukaemia and sarcoma viruses.
    Chermann JC; Raynaud M; Jasmin C; Mathé G
    Nature; 1970 Jul; 227(5254):173-4. PubMed ID: 4316954
    [No Abstract]   [Full Text] [Related]  

  • 24. N-salicylidene derivatives of pirarubicin.
    Ajito K; Ikeda D; Komuro K; Nosaka C; Wako N; Kondo S; Takeuchi T
    J Antibiot (Tokyo); 1989 Jul; 42(7):1133-44. PubMed ID: 2753818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of the antitumour antibiotic streptonigrin with DNA and oligonucleotides.
    Long GV; Harding MM; Fan JY; Denny WA
    Anticancer Drug Des; 1997 Sep; 12(6):453-72. PubMed ID: 9311555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Friend virus replication by a compound that reacts with the nucleocapsid zinc finger: anti-retroviral effect demonstrated in vivo.
    Ott DE; Hewes SM; Alvord WG; Henderson LE; Arthur LO
    Virology; 1998 Apr; 243(2):283-92. PubMed ID: 9568028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo effect of a new mineral condensed ion (HPA 39) on murine Friend leukaemia.
    Larnicol N; Augery Y; Le Bousse-Kerdiles C; Degiorgis V; Chermann JC; Teze A; Jasmin C
    J Gen Virol; 1981 Jul; 55(Pt 1):17-23. PubMed ID: 7299368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The quinoline quinone as the minimum entity for reverse transcriptase inhibitory activity of streptonigrin.
    Inouye Y; Take Y; Oogose K; Kubo A; Nakamura S
    J Antibiot (Tokyo); 1987 Jan; 40(1):105-7. PubMed ID: 2435693
    [No Abstract]   [Full Text] [Related]  

  • 29. Siloxane-based cross-coupling of bromopyridine derivatives: studies for the synthesis of streptonigrin and lavendamycin.
    McElroy WT; DeShong P
    Org Lett; 2003 Dec; 5(25):4779-82. PubMed ID: 14653672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative studies on resistance to anthracycline derivatives between doxorubicin-resistant mouse lymphoblastoma L5178Y cells and mouse leukemia P388 cells.
    Inouye Y; Oogose K; Nakamura S
    J Antibiot (Tokyo); 1990 Aug; 43(8):1021-7. PubMed ID: 2211351
    [No Abstract]   [Full Text] [Related]  

  • 31. Antitumor spectrum of deoxyspergualin and its lack of cross-resistance to other antitumor agents.
    Nishikawa K; Shibasaki C; Hiratsuka M; Arakawa M; Takahashi K; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1101-9. PubMed ID: 1955393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic activity of pretazettine, a narcissus alkaloid on Rauscher leukemia: comparison with tazettine and streptonigrin.
    Furusawa E; Furusawa S; Lee JY; Patanavanich S
    Proc Soc Exp Biol Med; 1976 Jun; 152(2):186-91. PubMed ID: 935182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Production conditions and properties of the new antineoplastic antibiotic No. 294].
    Brazhnikova MG; Kudinova MK; Vishniakova IA; Gauze GF; Preobrazhenskaia TP
    Antibiotiki; 1970 Aug; 15(8):675-8. PubMed ID: 5537044
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of treatment with a combination of 6-mercaptopurine and porfiromycin on an established Friend leukemia virus infection.
    Sidwell RW; Dixon GJ; Compton P; Schabel FM
    Cancer Res; 1969 Mar; 29(3):497-502. PubMed ID: 5773795
    [No Abstract]   [Full Text] [Related]  

  • 35. Potent antitumor antibiotic complex: PD 114,759, PD 115,028, PD 119,707, and PD 119,193.
    Tunac JB; Graham BD; Mamber SW; Dobson WE; Lenzini MD
    J Antibiot (Tokyo); 1985 Oct; 38(10):1337-43. PubMed ID: 3840793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of avian myeloblastosis virus reverse transcriptase by heterocyclic quinones: structure-activity correlation.
    Inouye Y; Matsumoto H; Morishige R; Kitahara Y; Kubo A; Nakamura S
    Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):994-8. PubMed ID: 1716528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure and function of "metalloantibiotics".
    Ming LJ
    Med Res Rev; 2003 Nov; 23(6):697-762. PubMed ID: 12939790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The activity of streptonigrin against the Rauscher murine leukemia virus in vivo.
    McBride TJ; Oleson JJ; Woolf D
    Cancer Res; 1966 Apr; 26(4):727-32. PubMed ID: 4286880
    [No Abstract]   [Full Text] [Related]  

  • 39. Free radical modes of cytotoxicity of adriamycin and streptonigrin.
    DeGraff W; Hahn SM; Mitchell JB; Krishna MC
    Biochem Pharmacol; 1994 Oct; 48(7):1427-35. PubMed ID: 7945443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. StnK2 catalysing a Pictet-Spengler reaction involved in the biosynthesis of the antitumor reagent streptonigrin.
    Wang X; Kong D; Huang T; Deng Z; Lin S
    Org Biomol Chem; 2018 Dec; 16(47):9124-9128. PubMed ID: 30483694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.